8.2 billion USD Chinese conglomerate plans investments into US healthcare ventures

China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…

China based Tsinghua discloses multiple-billion USD stake in Silicon Valley company

Tech companies around the world are among the many businesses benefiting from the recent flood of Chinese overseas direct investment. Tsinghua Holdings, a Chinese state-owned company, has recently disclosed an investment in Marvell Technology Group, a chip maker based in Silicon Valley. Although the size of the investment has not been specified, Tsinghua reported the…

A quick guide to cost control vs cost reduction

Accountants and credit controllers are on the frontline of ensuring an organisation’s financial health. This involves a number of key processes, including cost accounting. It is vital in today’s economy for accountants to be familiar with both cost reduction and cost control – two similar but significantly different ways to monitor and modify organisational costs.…

Chinese company acquires UK healthcare venture for 1.1 billion USD

In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…

Chinese investor makes multi-million dollar bid for French pharma company

Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…